Clearbridge Investments, LLC Invitae Corp Transaction History

Clearbridge Investments, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $13.2 Million - $32.9 Million	-2,107,357 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $120,319 - $234,663	-8,185 Reduced 0.39%	2,107,357 $32.2 Million
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $119,945 - $165,782	-4,934 Reduced 0.23%	2,115,542 $60.1 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $91,784 - $142,127	3,518 Added 0.17%	2,120,476 $71.5 Million
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $323,525 - $557,116	-9,786 Reduced 0.46%	2,116,958 $80.9 Million

Q4 2020 Feb 10, 2021	SELL	$39.09 - $57.4 $15,596 - $22,902	-399 Reduced 0.02%	2,126,744 $88.9 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $15,636 - $24,568	550 Added 0.03%	2,127,143 $92.2 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $71,934 - $186,071	6,143 Added 0.29%	2,126,593 $64.4 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $783,703 - $2.82 Million	102,579 Added 5.08%	2,120,450 $29 Million
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $15 Million - $20.6 Million	999,094 Added 98.07%	2,017,871 $33 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $19.2 Million - $28 Million	1,018,777 New	1,018,777 $19.6 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.